Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ocular Therapeutix

Request full access

Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye

Bedford, United StatesFounded 2006Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2014

Ocular Therapeutix in the Bedford ecosystem

Live from Dealroom

The Ocular Therapeutix office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later15 investors entered at this stage

  • Great Point Partners
  • Acuta Capital Partners
  • Versant Ventures
  • Ascension Ventures
  • SV Health Investors
  • Opaleye Management
  • Deep Track Capital
  • Baxter International
  • Ascension
  • TCGX
  • Logos Capital
  • Polaris Partners
  • Surveyor Capital
  • Venrock Healthcare Capital Partners
  • Perceptive Advisors
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Bedford HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$31M

34 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Ocular Therapeutix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.